Inventor · disambiguated record
Mark Stuart Chambers
Also filed as: CHAMBERS MARK · CHAMBERS MARK A · CHAMBERS MARK S · CHAMBERS MARK STUART
73 granted patents·9 pending applications·1,421 citations·filing 1991–2024
99Inventor score
Files withMERCK SHARP & DOHME32ANDREWS MARTIN JAMES INGLIS7GENENTECH INC7MERCK & CO INC6MERCK SHARPE & DOHME LTD5
Top patents by PatentIndex Score
82 records- 0199US5719147AMorpholine and thiomorpholine tachykinin receptor antagonistsMERCK & CO INC·Filed 1995·Granted Feb 17, 1998·193 cites·27 claims
- 0295US5556969ABenzodiazepine derivativesMERCK SHARP & DOHME·Filed 1995·Granted Sep 17, 1996·94 cites·7 claims
- 0394US9212173B2Pyrazole aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2014·Granted Dec 15, 2015·18 cites·3 claims
- 0494US5637699AProcess for preparing morpholine tachykinin receptor antagonistsMERCK & CO INC·Filed 1995·Granted Jun 10, 1997·85 cites·2 claims
- 0593US8815882B2Pyrazole aminopyrimidine derivatives as LRRK2 modulatorsBAKER-GLENN CHARLES·Filed 2011·Granted Aug 26, 2014·34 cites·22 claims
- 0693US8354420B2Aminopyrimidine derivatives as LRRK2 inhibitorsGENENTECH INC·Filed 2011·Granted Jan 15, 2013·27 cites·26 claims
- 0793US7176203B2Imidazo-triazine derivatives as ligands for gaba receptorsMERCK SHARP & DOHME·Filed 2003·Granted Feb 13, 2007·63 cites·7 claims
- 0893US5219860ASpirocyclic antipsychotic agentsMERCK SHARP & DOHME·Filed 1991·Granted Jun 15, 1993·54 cites·5 claims
- 0991US5208248AIndazole-substituted five-membered heteroaromatic compoundsMERCK SHARPE & DOHME LTD·Filed 1991·Granted May 4, 1993·49 cites·7 claims
- 1090US8791130B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Jul 29, 2014·18 cites·21 claims
- 1190US5618812ABenzodiazepine derivativesMERCK SHARP & DOHME·Filed 1993·Granted Apr 8, 1997·89 cites·18 claims
- 1290US5360802ABenzodiazepine derivatives, compositions containing them and their use in therapyMERCK SHARPE & DOHME LTD·Filed 1992·Granted Nov 1, 1994·47 cites·15 claims
- 1389US11248001B2PCSK9 inhibitors and methods of use thereofASTRAZENECA AB·Filed 2020·Granted Feb 15, 2022·6 cites·6 claims
- 1489US9145402B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Sep 29, 2015·15 cites·20 claims
- 1589US7915256B2Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseasesGALAPAGOS NV·Filed 2009·Granted Mar 29, 2011·12 cites·50 claims
- 1689US7501411B2Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseasesGALAPAGOS NV·Filed 2007·Granted Mar 10, 2009·12 cites·54 claims
- 1788US8802674B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Aug 12, 2014·12 cites·15 claims
- 1888US8796296B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Aug 5, 2014·14 cites·21 claims
- 1986US8809331B2Aminopyrimidine derivatives as LRRK2 modulatorsGENENTECH INC·Filed 2012·Granted Aug 19, 2014·12 cites·5 claims
- 2086US6235735B1Morpholine and thiomorpholine tachykinin receptor antagonistsMERCK & CO INC·Filed 2000·Granted May 22, 2001·19 cites·18 claims
- 2185US11806346B2HTT modulators for treating Huntington's diseaseCHDI FOUNDATION INC·Filed 2021·Granted Nov 7, 2023·1 cites·37 claims
- 2285US6900215B2Imidazo-pyrimidine derivatives as ligands for gaba receptorsMERCK SHARP & DOHME·Filed 2002·Granted May 31, 2005·16 cites·28 claims
- 2385US6730681B2Triazolo-pyrimidine derivatives as ligands for gaba receptorsMERCK SHARP & DOHME·Filed 2000·Granted May 4, 2004·18 cites·12 claims
- 2484US8133895B2Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseasesANDREWS MARTIN JAMES INGLIS·Filed 2008·Granted Mar 13, 2012·7 cites·13 claims
- 2584US5597915ABenzodiazepine derivatives, compositions containing them and their use in therapyMERCK SHARP & DOHME·Filed 1993·Granted Jan 28, 1997·51 cites·4 claims
- 2683US5681833ABenzodiazepine derivativesMERCK SHARP & DOHME·Filed 1993·Granted Oct 28, 1997·50 cites·11 claims
- 2782US7005431B2Imidazo-triazine derivatives as ligands for gaba receptorsMERCK SHARP & DOHME·Filed 2003·Granted Feb 28, 2006·21 cites·10 claims
- 2882US6936608B2Imidazo-triazine derivatives as ligands for GABA receptorsMERCK SHARP & DOHME·Filed 2001·Granted Aug 30, 2005·20 cites·17 claims
- 2981US6156787ASubstituted thienlycyclohexanone derivatives for enhancing cognitionMERCK SHARP & DOHME·Filed 1999·Granted Dec 5, 2000·28 cites·7 claims
- 3080US6395905B1Tetrahydroindazole derivatives as ligands for GABA-A α 5 receptorsMERCK SHARP & DOHME·Filed 2000·Granted May 28, 2002·16 cites·8 claims
- 3179US8012983B2Substituted triazolopyrazines useful for the treatment of degenerative and inflammatory diseasesGALAPAGOS NV·Filed 2009·Granted Sep 6, 2011·4 cites·12 claims
- 3279US6395766B1Tetrahydroindolone derivatives as gabaaalpha5 ligands for enhancing cognitionMERCK SHARP & DOHME·Filed 1999·Granted May 28, 2002·27 cites·7 claims
- 3378US7030128B2Imidazo-pyrimidine derivatives as ligands for GABA receptorsMERCK SHARP & DOHME·Filed 2002·Granted Apr 18, 2006·11 cites·10 claims
- 3477US7893058B2Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseasesJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Feb 22, 2011·2 cites·55 claims
- 3577US5604240APyrrolo-pyridine derivativesMERCK SHARP & DOHME·Filed 1995·Granted Feb 18, 1997·21 cites·5 claims
- 3676US10130619B2Amido thiadiazole derivatives as NADPH oxidase inhibitorsGENKYOTEX SUISSE SA·Filed 2015·Granted Nov 20, 2018·3 cites·12 claims
- 3776US6900209B2Nitrogen substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives for enhancing cognitionMERCK SHARP & DOHME·Filed 2001·Granted May 31, 2005·8 cites·10 claims
- 3876US5973156APiperidine and tetrahydropyridine derivativesMERCK SHARP & DOME LTD·Filed 1996·Granted Oct 26, 1999·25 cites·12 claims
- 3976US5854268AAzetidine, pyrrolidine and piperidine derivativesMERCK SHARP & DOHME·Filed 1995·Granted Dec 29, 1998·45 cites·10 claims
- 4075US10538530B2Vasopressin receptor antagonists and products and methods related theretoBLACKTHORN THERAPEUTICS INC·Filed 2018·Granted Jan 21, 2020·1 cites·104 claims
- 4174US5872116AMorpholine and thiomorpholine tachykinin receptor antagonistsMERCK & CO INC·Filed 1997·Granted Feb 16, 1999·14 cites·21 claims
- 4272US6048859AMorpholine and thiomorpholine tachykinin receptor antagonistsMERCK & CO INC·Filed 1999·Granted Apr 11, 2000·26 cites·23 claims
- 4371US6638930B2Morpholine and thiomorpholine tachykinin receptor antagonistsMERCK & CO INC·Filed 2001·Granted Oct 28, 2003·1 cites·4 claims
- 4470US5324733ASpirocyclic antipsychotic agentsMERCK SHARPE & DOHME LTD·Filed 1993·Granted Jun 28, 1994·32 cites·6 claims
- 4568US6355638B1Pyrazolo[1,5-d][1,2,4] triazines for enhancing cognitionMERCK SHARP & DOHME·Filed 2000·Granted Mar 12, 2002·4 cites·9 claims
- 4666US7482457B2Substituted quinoline-4-carboxylic hydrazides as NK-2/NK-3 receptor ligandsMERCK SHARP & DOHME·Filed 2004·Granted Jan 27, 2009·2 cites·12 claims
- 4766US7144887B2Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognitionMERCK SHARP & DOHME·Filed 2000·Granted Dec 5, 2006·3 cites·7 claims
- 4865US12465603B2Phthalazinone based modulators for the treatment of diseaseSOLEY THERAPEUTICS INC·Filed 2024·Granted Nov 11, 2025·0 cites·10 claims
- 4965US7094777B25-HT2A receptor ligandsMERK SHARP & DOHME LTD·Filed 2004·Granted Aug 22, 2006·5 cites·24 claims
- 5063US2007117847A1N-(3-(4-Substituted-1-piperiding1)-1-phenylpropyl) substituted sulfonamides as NK-3 receptor antagonistsCHAMBERS MARK S·Filed 2006·Application pending·0 cites
Showing the top 50 of 82 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →